Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aropax
2. Brl 29060
3. Brl-29060
4. Brl29060
5. Fg 7051
6. Fg-7051
7. Fg7051
8. Paroxetine
9. Paroxetine Hydrochloride
10. Paroxetine Hydrochloride Anhydrous
11. Paroxetine Hydrochloride Hemihydrate
12. Paroxetine Hydrochloride, Hemihydrate
13. Paroxetine Maleate
14. Paroxetine, Cis-(+)-isomer
15. Paroxetine, Cis-(-)-isomer
16. Paroxetine, Trans-(+)-isomer
17. Paxil
18. Seroxat
1. 72471-80-8
2. Ypo0ntk49o
3. Acetic Acid;(3s,4r)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
4. Unii-ypo0ntk49o
5. Schembl4200728
6. Dtxsid70222772
7. Paroxetine Acetate [who-dd]
8. Q27294647
9. Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3s-trans)-, Acetate
10. Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, Acetate (1:1), (3s,4r)-
Molecular Weight | 389.4 g/mol |
---|---|
Molecular Formula | C21H24FNO5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 389.16385103 g/mol |
Monoisotopic Mass | 389.16385103 g/mol |
Topological Polar Surface Area | 77 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 433 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Cytochrome P-450 CYP2D6 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6. (See all compounds classified as Cytochrome P-450 CYP2D6 Inhibitors.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15463
Submission : 2001-05-29
Status : Inactive
Type : II
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?